Treatment of Guillain-Barré Syndrome with Elevated CPK Levels

Diagnostic Considerations

• Elevated CPK in GBS requires careful diagnostic evaluation to rule out other conditions that may mimic GBS, such as acute rhabdomyolysis, myopathy, or critical illness polyneuropathy 4
• CPK testing is part of the recommended workup for neuropathy phenotype determination, alongside other tests including HbA1c, vitamin B12, TSH, vitamin B6, folate, serum protein electrophoresis, and immunofixation 5

Treatment Algorithm

• The American College of Physicians recommends intravenous immunoglobulin (IVIg) at 0.4 g/kg/day for 5 days (total dose 2 g/kg) or plasma exchange (5 sessions at 200-250 ml/kg) as first-line treatment for patients with GBS and elevated CPK levels 1, 2
• Nonopioid management of neuropathic pain with gabapentin, pregabalin, or duloxetine is recommended 1, 6

Special Considerations

• Elevated CPK may indicate muscle involvement or rhabdomyolysis, requiring additional monitoring of renal function and adequate hydration 4
• Monitor for cardiac complications, as elevated CPK may also reflect cardiac muscle involvement 3

Supportive Care

• Regular assessment of respiratory function is essential to identify early signs of respiratory failure 3
• Treatment of constipation/ileus which is common in GBS patients 1, 2

Pitfalls and Caveats

• Avoid medications that can worsen neuromuscular function, such as β-blockers, IV magnesium, fluoroquinolones, aminoglycosides, and macrolides 2, 6
• Corticosteroids alone are not recommended for GBS treatment as they have shown no significant benefit and may even have negative effects 3